Skip to content
Open access

Predictive Value of the Systemic Immune-Inflammation Index for Cardiovascular Events in Patients With Chronic Total Coronary Occlusion

Sep 2026 · Reviews in cardiovascular medicine · Vol 27 · 0 citations · 48 references
Medicine

TL;DR

Baseline SII is a reliable and independent predictor of MACEs in patients with CTO after PCI, with superior predictive performance compared with conventional inflammatory markers.

Abstract

Background: This large-scale cohort study aimed to evaluate the prognostic role of the systemic immune-inflammation index (SII) in patients with chronic total occlusion (CTO) undergoing percutaneous coronary intervention (PCI). Methods: A total of 3107 patients with CTO lesions who underwent PCI were enrolled in this study. Clinical characteristics were collected, and post-discharge major adverse cardiovascular events (MACEs) were recorded during follow-up, including all-cause mortality, non-fatal myocardial infarction, unplanned revascularization, and heart failure-related readmission. Patients were stratified into three groups according to SII tertiles: the low SII group (SII ≤447.66, n = 1036), the intermediate SII group (447.66 < SII < 679.89, n = 1039), and the high SII group (SII ≥679.89, n = 1032). Results: Over a median follow-up of 2.58 (2.33–2.92) years, 356 (11.5%) MACEs occurred, including 49 (1.6%) all-cause deaths, 105 (3.4%) non-fatal myocardial infarctions, 164 (5.3%) revascularizations, and 38 (1.2%) heart failure rehospitalizations. Multivariable Cox regression analyses demonstrated that elevated SII was independently linked to higher risks of MACEs (hazard ratio [HR] = 1.51, 95% confidence interval [CI]: 1.20–1.90; p = 0.001), all-cause death (HR = 2.06, 95% CI: 1.11–3.84; p = 0.022), non-fatal myocardial infarction (HR = 1.76, 95% CI: 1.15–2.69; p = 0.009), and repeat revascularization (HR = 1.32, 95% CI: 1.01–1.76; p = 0.046) after full adjustment. Kaplan–Meier survival curves showed significantly higher rates of adverse events in patients with elevated SII. Adding SII to traditional risk models improved predictive performance, as reflected by increases in the concordance index (C-index), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Conclusions: Baseline SII is a reliable and independent predictor of MACEs in patients with CTO after PCI, with superior predictive performance compared with conventional inflammatory markers.

Read PDF

Similar papers

Open access Oct 2026

Prognostic value of twelve systemic inflammatory indices for composite cardiovascular events in chronic coronary syndrome patients with or without diabetes undergoing PCI

In diabetic patients with CCS, inflammatory indices such as SII, NLR, and PAR are strong predictors of PCI-related complications, including RR and ISR, and may serve as practical tools for risk stratification.

L. Liu, W.-J.-L. Wang, M. Lihong · 0 citations
Open access Nov 2026

Association between systemic inflammatory response index and the severity of coronary artery lesions in patients undergoing coronary angiography for the first time

Inflammation drives coronary artery disease (CAD). The systemic inflammation response index (SIRI) reflects systemic inflammatory status, yet its association with CAD severity in first-time coronary angiography patients remains unclear. This retrospective study included 219 inpatients undergoing initial coro...

Tian-Kun Wu, Hong-Hui Yang, Yu-Qing Yang et al. · 0 citations
Open access Oct 2026

Prognostic Value of the Atherogenic Index of Plasma for Severity and Cardiovascular Outcomes in Young Patients (≤35 Years) with Coronary Artery Disease: A Retrospective Study

The findings support AIP as a practical tool not only for early risk stratification but also for guiding intensive lipid-lowering therapy in this distinct population of young CAD patients.

Jia-Yin Sun, Jia-Yi Liu, Yu-Ning Wang et al. · 0 citations
Open access Nov 2026

Remnant cholesterol inflammation index predicts adverse outcomes in patients with acute myocardial infarction: a single-center retrospective study

Despite treatment, residual cardiovascular and cerebrovascular risk persists post-acute myocardial infarction (AMI). The Remnant Cholesterol Inflammation Index (RCII), combining residual cholesterol and hsCRP, reflects lipid and inflammatory burdens; however, its prognostic value in the acute phase remains unclear....

Xin-Yue Chen, Yi-Chen Li, Jian-Wei Ma et al. · 0 citations
Open access Oct 2026

Evaluation of systemic immune-inflammation index in young patients with coronary artery disease: association with glycaemic status

Background: Coronary artery disease (CAD) in young adults is an important health concern, particularly in India. The Systemic Immune-Inflammation Index (SII) is a composite inflammatory marker derived from platelet, neutrophil and lymphocyte counts. However, limited information is available regarding its relationship w...

Rishitha Bygari, S. Thomas, B. Ramaiah · 0 citations
Open access Oct 2026

Inflammatory indices significantly improve one-year mortality prediction in STEMI patients: a large-scale multi-center study

Inflammation is crucial to the pathogenesis, progression, and prognosis of ST-segment elevation myocardial infarction (STEMI). Routine complete blood count-derived inflammatory indices—neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and monocyte-...

Fang-Jie Ji, J. Liu, R. Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.